D64.81

Anemia due to antineoplastic chemotherapy

Billable / specific

D64.81 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Inclusion terms

Not coded here — never report together with this code.

refractory anemia (D46.-) (from D64)
refractory anemia with excess blasts in transformation [RAEB T] (C92.0-) (from D64)

Not included here — may be reported together when both conditions exist.

anemia in neoplastic disease (D63.0)
aplastic anemia due to antineoplastic chemotherapy (D61.1)
autoimmune disease (systemic) NOS (M35.9) (from D64)
certain conditions originating in the perinatal period (P00-P96) (from D64)
complications of pregnancy, childbirth and the puerperium (O00-O9A) (from D64)
congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) (from D64)
endocrine, nutritional and metabolic diseases (E00-E88) (from D64)
human immunodeficiency virus [HIV] disease (B20) (from D64)
injury, poisoning and certain other consequences of external causes (S00-T88) (from D64)
neoplasms (C00-D49) (from D64)
symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from D64)